TYK209: Difference between revisions
Bot: Automated import of articles |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| (One intermediate revision by the same user not shown) | |||
| Line 36: | Line 36: | ||
<p style="text-align: center;">[[TYK208|<Prev Question]] --- [[TYK210|Next Question>]]</p> | <p style="text-align: center;">[[TYK208|<Prev Question]] --- [[TYK210|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
Latest revision as of 02:18, 25 September 2026
A 3-week old female is scheduled for palliative repair of tetralogy of Fallot. She is currently receiving an infusion of prostaglandin. Which of the following agents, given at standard clinical doses, WILL affect the direction of flow through her current shunt?
a) Isoflurane
b) Pancuronium
c) Propofol
d) Ketamine
e) Fentanyl
Answer
Answer c. Palliative repair of tetralogy of Fallot involves placement of a modified Blalock-Taussig shunt. This replaces the ductus arteriosus which is maintained by an infusion of prostaglandin. Flow through either shunt will be determined by balance of SVR and PVR and those drugs that affect one more than the other will affect the direction of flow. In normal doses, pancuronium, isoflurane, sevoflurane, ketamine and opiates do not affect the shunt direction, unlike propofol which can decrease SVR significantly, reverse shunt flow and result in worsening cyanosis.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.